BrightSpring Health Services, Inc. (NASDAQ:BTSG) Receives $18.50 Consensus PT from Analysts

BrightSpring Health Services, Inc. (NASDAQ:BTSG) has been given an average rating of “Moderate Buy” by the fifteen ratings firms that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $18.65.

A number of research analysts have weighed in on the stock. KeyCorp assumed coverage on shares of BrightSpring Health Services in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. BTIG Research boosted their price objective on shares of BrightSpring Health Services from $15.00 to $20.00 and gave the company a “buy” rating in a research report on Thursday, October 3rd. Wells Fargo & Company increased their target price on BrightSpring Health Services from $17.00 to $21.00 and gave the stock an “overweight” rating in a report on Wednesday, November 27th. Guggenheim boosted their price target on BrightSpring Health Services from $15.00 to $18.00 and gave the company a “buy” rating in a report on Tuesday, October 1st. Finally, Bank of America increased their price objective on BrightSpring Health Services from $19.00 to $21.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Virtu Financial LLC bought a new position in shares of BrightSpring Health Services in the third quarter valued at $522,000. Geode Capital Management LLC lifted its stake in BrightSpring Health Services by 0.6% in the third quarter. Geode Capital Management LLC now owns 1,304,214 shares of the company’s stock valued at $19,150,000 after acquiring an additional 7,750 shares during the last quarter. Barclays PLC grew its position in shares of BrightSpring Health Services by 22.2% in the 3rd quarter. Barclays PLC now owns 393,725 shares of the company’s stock valued at $5,780,000 after acquiring an additional 71,633 shares during the period. State Street Corp increased its stake in shares of BrightSpring Health Services by 7.4% during the 3rd quarter. State Street Corp now owns 1,239,628 shares of the company’s stock worth $18,198,000 after purchasing an additional 85,464 shares during the last quarter. Finally, Verition Fund Management LLC raised its holdings in shares of BrightSpring Health Services by 34.2% in the 3rd quarter. Verition Fund Management LLC now owns 132,918 shares of the company’s stock valued at $1,951,000 after purchasing an additional 33,890 shares during the period.

BrightSpring Health Services Stock Performance

Shares of BrightSpring Health Services stock opened at $17.13 on Monday. The stock’s fifty day simple moving average is $17.64 and its 200 day simple moving average is $14.19. The company has a current ratio of 1.35, a quick ratio of 0.97 and a debt-to-equity ratio of 1.63. The company has a market capitalization of $2.98 billion and a PE ratio of -65.88. BrightSpring Health Services has a 12 month low of $7.85 and a 12 month high of $20.25.

BrightSpring Health Services (NASDAQ:BTSG) last released its quarterly earnings results on Friday, November 1st. The company reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.07). BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. The business had revenue of $2.91 billion for the quarter, compared to analyst estimates of $2.72 billion. The firm’s quarterly revenue was up 28.8% compared to the same quarter last year. On average, research analysts predict that BrightSpring Health Services will post 0.59 EPS for the current year.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.